CellCentric Company Profile, Contacts & Intelligence
CellCentric Overview
Inobrodib is the first small molecule drug in the clinic targeting twin proteins p300 and CBP. It is formulated as a capsule taken orally. p300/CBP are twin (paralogue) acetyl transferases, and importantly, gene activating proteins that are known to play an important role in the progression of certain cancers. CellCentric’s pioneering drug is in Phase I/II clinical trials to evaluate its effectiveness to treat specific solid tumours, as well as haematological malignancies (blood cancers). These represent major clinical unmet needs, delivering a new therapy for people with cancer, who otherwise have few alternatives.
- Headquarters
- Little Chesterford, United Kingdom
- Website
- www.cellcentric.com
- Industry
- Biotechnology
CellCentric Contact Intelligence
See which contact channels and departments are represented in the visible AeroLeads data.
CellCentric People & Org Chart Preview
Sample people records show job titles and whether email or phone data is available without exposing raw contact details.
CellCentric Workforce Composition
Seniority breakdown across 3 visible profiles.
Compare Similar Companies to CellCentric
Explore companies in related markets and compare their industry and employee estimates.
| Company | Industry / match | Employee estimate | Page |
|---|---|---|---|
| Autolus Therapeutics | Biotechnology | 736 | View company |
| cellcentric GmbH & Co. KG | Fuel Cell Manufacturing | 382 | View company |
| Bicycle Therapeutics | Biotechnology Research | 344 | View company |
| Quell Therapeutics | Biotechnology Research | 151 | View company |
| Amphista Therapeutics Limited | Biotechnology Research | 65 | View company |
| Apollo Therapeutics | Biotechnology Research | 61 | View company |
| Evox Therapeutics Ltd | Research Services | 45 | View company |
| Ellipses Pharma | Biotechnology | 35 | View company |
| AstronauTx | Biotechnology Research | 15 | View company |
| Crescendo Biologics Limited | Biotechnology Research | 12 | View company |